Reliance Infrastructure Other Announcement

Reliance Infrastructure Other Announcement

Reliance Infrastructure Ltd has filed its quarterly shareholding pattern for the quarter ended September 30, 2026. This is a routine regulatory compliance filing.

Reliance Infrastructure Legal & Regulatory

Reliance Infrastructure Limited has been named as an accused in a second chargesheet filed by the CBI regarding the Reliance Home Finance Limited matter.

Reliance Infrastructure Adverse Business Impact

Reliance Infrastructure's subsidiary, MMOPL, had its Master Restructuring Agreement (MRA) with NARCL revoked due to unfulfilled conditions precedent. The financial impact currently remains unascertainable.

Reliance Infrastructure Insolvency Petition

IIFC (UK) filed an IBC Section 7 petition against Reliance Infrastructure's subsidiary, MMOPL, at NCLT Mumbai claiming approximately USD 182 Million.

Value

₹18.20 Cr

Reliance Infrastructure Insolvency Petition

Reliance Infrastructure's JV, Mumbai Metro One, faces an IBC petition from IIFC for ~USD 182 million. NARCL also revoked a debt restructuring agreement for the JV.

Value

₹1,747 Cr

Reliance Infrastructure Legal & Regulatory

Reliance Infrastructure has been named as a proposed accused in a Directorate of Enforcement complaint involving an alleged amount of Rs. 179.66 Crore.

Value

₹179.7 Cr

Mahindra & Mahindra Financial Services Other Announcement

Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.

ACME Solar Holdings Other Announcement

ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.

eMudhra Other Announcement

eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.

Aarti Pharmalabs Other Announcement

Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.

Sagarsoft (India) Other Announcement

Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.

Sadhana Nitro Chem Other Announcement

Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.